Tuboi SH, Costa ZGA, da Costa Vasconcelos PF, Hatch D, 2007. Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002. Trans R Soc Trop Med Hyg 101: 169–175.

TuboiSHCostaZGAda Costa VasconcelosPFHatchD, 2007. Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002. Trans R Soc Trop Med Hyg 101: 169–175.)| false
• Search Google Scholar
• Export Citation

Monath TP, Vasconcelos PFC, 2015. Yellow fever. J Clin Virol 64: 160–173.

MonathTPVasconcelosPFC, 2015. Yellow fever. J Clin Virol 64: 160–173.)| false
• Search Google Scholar
• Export Citation

Monath TP, 2008. Treatment of yellow fever. Antiviral Res 78: 116–124.

MonathTP, 2008. Treatment of yellow fever. Antiviral Res 78: 116–124.)| false
• Search Google Scholar
• Export Citation

Klitting R, Fischer C, Drexler JF, Gould EA, Roiz D, Paupy C, de Lamballerie X, 2018. What does the future hold for yellow fever virus? (II). Genes (Basel) 425.

KlittingRFischerCDrexlerJFGouldEARoizDPaupyCde LamballerieX, 2018. What does the future hold for yellow fever virus? (II). Genes (Basel) 425.)| false
• Search Google Scholar
• Export Citation

Domingo C, Patel P, Yillah J, Weidmann M, Méndez JA, Nakouné ER, Niedriga M, 2012. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol 50: 4054–4060.

DomingoCPatelPYillahJWeidmannMMéndezJANakounéERNiedrigaM, 2012. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol 50: 4054–4060.)| false
• Search Google Scholar
• Export Citation

Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823–1826.

MartinDAMuthDABrownTJohnsonAJKarabatsosNRoehrigJT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823–1826.)| false
• Search Google Scholar
• Export Citation

Karvellas CJ, Subramanian RM, 2016. Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure. Crit Care Clin 32: 439–451.

KarvellasCJSubramanianRM, 2016. Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure. Crit Care Clin 32: 439–451.)| false
• Search Google Scholar
• Export Citation

Larsen FS et al. 2016. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64: 69–78.

LarsenFS 2016. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 64: 69–78.)| false
• Search Google Scholar
• Export Citation

van de Weg CA et al. 2014. Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances. PLoS Negl Trop Dis 8: e3214.

van de WegCA 2014. Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances. PLoS Negl Trop Dis 8: e3214.)| false
• Search Google Scholar
• Export Citation

McElroy AK et al. 2019. Macrophage activation marker soluble CD163 associated with fatal and severe Ebola virus disease in humans. Emerg Infect Dis 25: 290–298.

McElroyAK 2019. Macrophage activation marker soluble CD163 associated with fatal and severe Ebola virus disease in humans. Emerg Infect Dis 25: 290–298.)| false
• Search Google Scholar
• Export Citation

Kernan KF, Carcillo JA, 2017. Hyperferritinemia and inflammation. Int Immunol 29: 401–409.

KernanKFCarcilloJA, 2017. Hyperferritinemia and inflammation. Int Immunol 29: 401–409.)| false
• Search Google Scholar
• Export Citation

Quaresma JA, Barros VL, Pagliari C, Fernandes ER, Andrade HF, Vasconcelos PF, Duarte MI, 2007. Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg 101: 161–168.

QuaresmaJABarrosVLPagliariCFernandesERAndradeHFVasconcelosPFDuarteMI, 2007. Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg 101: 161–168.)| false
• Search Google Scholar
• Export Citation

Quaresma JA, Barros VL, Pagliari C, Fernandes ER, Guedes F, Takakura CF, Andrade HF, Vasconcelos PF, Duarte MI, 2006. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-β, TNF-α and NK cells activity. Virology 345: 22–30.

QuaresmaJABarrosVLPagliariCFernandesERGuedesFTakakuraCFAndradeHFVasconcelosPFDuarteMI, 2006. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-β, TNF-α and NK cells activity. Virology 345: 22–30.)| false
• Search Google Scholar
• Export Citation

Quaresma JA, Lima LW, Fuzii HT, Libonati RM, Pagliari C, Duarte MI, 2010. Immunohistochemical evaluation of macrophage activity and its relationship with apoptotic cell death in the polar forms of leprosy. Microb Pathog 49: 135–140.

QuaresmaJALimaLWFuziiHTLibonatiRMPagliariCDuarteMI, 2010. Immunohistochemical evaluation of macrophage activity and its relationship with apoptotic cell death in the polar forms of leprosy. Microb Pathog 49: 135–140.)| false
• Search Google Scholar
• Export Citation

Engelmann F et al. 2014. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLoS Negl Trop Dis 8: e3295.

EngelmannF 2014. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model. PLoS Negl Trop Dis 8: e3295.)| false
• Search Google Scholar
• Export Citation

Wamala JF et al. 2012. Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010–January 2011. Int J Infect Dis 16: e536–e542.

WamalaJF 2012. Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010–January 2011. Int J Infect Dis 16: e536–e542.)| false
• Search Google Scholar
• Export Citation

Basler CF, 2017. Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol 39: 551–561.

BaslerCF, 2017. Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol 39: 551–561.)| false
• Search Google Scholar
• Export Citation

Monath TP, Brinker KR, Chandler FW, Kemp GE, Cropp CB, 1981. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am J Trop Med Hyg 30: 431–443.

MonathTPBrinkerKRChandlerFWKempGECroppCB, 1981. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am J Trop Med Hyg 30: 431–443.)| false
• Search Google Scholar
• Export Citation

Demirkol D et al. Turkish Secondary HLH/MAS Critical Care Study Group, 2012. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit Care 16: R52.

DemirkolD Turkish Secondary HLH/MAS Critical Care Study Group, 2012. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit Care 16: R52.)| false
• Search Google Scholar
• Export Citation

Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y, 2013. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 11: 185.

RosárioCZandman-GoddardGMeyron-HoltzEGD’CruzDPShoenfeldY, 2013. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 11: 185.)| false
• Search Google Scholar
• Export Citation